Metrics

The numbers behind Zoetis Inc.: as-reported financial statements and company metrics for FY2021–FY2025, traced to the source filings, opened with the share-price history those statements have to justify. Every linked figure opens the exact page of the filing it was printed on, with the statement row highlighted. Amounts in US$ millions unless noted.

Reading notes: Every FY2021–FY2025 figure in the four core statements and the segment table is taken from that year's own Zoetis Form 10-K (each 10-K prints three years of income/cash-flow and two years of balance sheet); each cell links to the exact statement page. Revenue breakdown uses Zoetis' reported 'Revenue by species' disaggregation (Note 4). Companion Animal and Livestock are the printed species subtotals; a Contract manufacturing human health line and a Total Revenue row complete the split. The Operating Segments statement shows Zoetis' two reportable segments (U.S. and International) with segment revenue, segment earnings and gross margin, reconciled by 'Total operating segments' earnings (Note 19, Selected Statement of Income Information). FY2016–FY2020 figures in the Long-Term Record are from the standardized SEC XBRL data feed and are shown without page links (those filings are not in the corpus).

Share Price — Full Available History — 13 Years

The stock closed at $76.00 on Jul 18, 2026 — up 145% over the window shown (+6.9% a year), trading between $28.40 and $247.03. At that close the stock trades at 13× FY2025 diluted EPS as reported below.

Source: market price feed, monthly closes, sampled from 3,383 source observations, Feb 2013–Jul 2026. Price return only, excludes dividends.

FY2025 at a Glance

Source: FY2025 consolidated statements [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Revenue by Species

Revenue by Species	FY2021	FY2022	FY2023	FY2024	FY2025
Companion Animal	4,689	5,203	5,576	6,278	6,587
Livestock	3,005	2,791	2,890	2,898	2,764
Contract manufacturing human health	82	86	78	80	116
Total Revenue	7,776	8,080	8,544	9,256	9,467
Total Revenue growth, derived	—	+3.9%	+5.7%	+8.3%	+2.3%

Source: Form 10-K Note 4 — Revenue (Revenue by species) [5] [6] [7] [8]. Click any linked figure to open the filing page with the row highlighted.

Operating Segments — Revenue Earnings

Operating Segments — Revenue Earnings	FY2021	FY2022	FY2023	FY2024	FY2025
U.S. Revenue	4,042	4,313	4,555	5,074	5,097
U.S. Earnings	2,569	2,763	2,863	3,336	3,438
U.S. Gross Margin	80.5%	81.4%	80.2%	81.6%	83.5%
International Revenue	3,652	3,681	3,911	4,102	4,254
International Earnings	1,948	1,990	2,037	2,118	2,264
International Gross Margin	69.7%	70.6%	68.4%	68.0%	69.2%
Total operating segments	4,517	4,753	4,900	5,454	5,702

Source: Form 10-K Note 19 — Segment Information (U.S. and International reportable segments) [9] [10] [11] [12]. Click any linked figure to open the filing page with the row highlighted.

Income Statement

Source: Consolidated Statements of Income [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Columns marked E are consensus analyst estimates shown alongside reported results for direct comparison; they are not company guidance.

Estimate source: Yahoo Finance analyst consensus, as of 2026-07-20. Estimate figures link to the consensus source, not to filing pages.

Balance Sheet

Source: Consolidated Balance Sheets [13] [14] [15] [16]. Click any linked figure to open the filing page with the row highlighted.

Cash Flow

Source: Consolidated Statements of Cash Flows [17] [18] [19] [20]. Click any linked figure to open the filing page with the row highlighted.

Non-GAAP Operating Results

Non-GAAP Operating Results	FY2021	FY2022	FY2023	FY2024	FY2025
Adjusted net income	2,240	2,297	2,457	2,693	2,847
Adjusted diluted EPS	4.70	4.88	5.32	5.92	6.41
Effective tax rate on adjusted pretax income	18.6%	20.3%	20.1%	19.8%	20.3%

Source: company filings [21] [22] [23]. Click any linked figure to open the filing page with the row highlighted.

Reported Margins Returns

Reported Margins Returns	FY2021	FY2022	FY2023	FY2024	FY2025
Cost of sales (% of revenue)	29.6%	30.4%	30.0%	29.4%	28.2%
Income before income taxes (% of revenue)	32.0%	33.0%	34.0%	34.0%	35.0%
Net income (% of revenue)	26.0%	26.0%	27.0%	27.0%	28.0%
Effective tax rate	18.2%	20.5%	20.3%	20.3%	20.4%

Source: company filings [24] [25]. Click any linked figure to open the filing page with the row highlighted.

Capital Returns to Shareholders

Capital Returns to Shareholders	FY2021	FY2022	FY2023	FY2024	FY2025
Dividends declared per common share	1.07	1.35	1.56	1.80	2.03
Dividends declared	509	631	716	812	897
Common shares repurchased (millions)	4	10	6	10	24

Source: company filings [26] [1] [27] [3]. Click any linked figure to open the filing page with the row highlighted.

People Innovation

People Innovation	FY2021	FY2022	FY2023	FY2024	FY2025
Total employees (worldwide)	12,100	13,800	14,100	13,800	14,500
Global voluntary attrition rate	—	—	—	8.0%	7.0%
R D employees (global)	—	—	—	—	1,700
Sales organization (field force)	—	—	—	—	3,900

Source: company filings [28] [29] [30] [31]. Click any linked figure to open the filing page with the row highlighted.

Long-Term Record

Fiscal year	Total revenue	Net income attributable to Zoetis Inc.	Diluted earnings per share	Operating cash flow	Capital expenditures
FY2016	4,888	821	1.65	713	216
FY2017	5,307	864	1.75	1,346	224
FY2018	5,825	1,428	2.93	1,790	338
FY2019	6,260	1,500	3.11	1,795	460
FY2020	6,675	1,638	3.42	2,126	453
FY2021	7,776	2,037	4.27	2,213	477
FY2022	8,080	2,114	4.49	1,912	586
FY2023	8,544	2,344	5.07	2,353	732
FY2024	9,256	2,486	5.47	2,953	655
FY2025	9,467	2,673	6.02	2,904	621

Source: consolidated statements across filings; older years from the standardized feed [17] [1] [18] [2]. Click any linked figure to open the filing page with the row highlighted.

Analyst Consensus

Estimate source: Yahoo Finance analyst consensus, as of 2026-07-20. Estimate figures link to the consensus source, not to filing pages.

Traceability

369 of 394 figures on this page (94%) link to the filing page where they are printed — click a linked figure to open the source PDF at that page with the row highlighted. Unlinked figures come from standardized data feeds or pre-filing years.

• Every FY2021–FY2025 figure in the four core statements and the segment table is taken from that year's own Zoetis Form 10-K (each 10-K prints three years of income/cash-flow and two years of balance sheet); each cell links to the exact statement page.

• Revenue breakdown uses Zoetis' reported 'Revenue by species' disaggregation (Note 4). Companion Animal and Livestock are the printed species subtotals; a Contract manufacturing human health line and a Total Revenue row complete the split.

• The Operating Segments statement shows Zoetis' two reportable segments (U.S. and International) with segment revenue, segment earnings and gross margin, reconciled by 'Total operating segments' earnings (Note 19, Selected Statement of Income Information).

• FY2016–FY2020 figures in the Long-Term Record are from the standardized SEC XBRL data feed and are shown without page links (those filings are not in the corpus).

• FY2025 was recast in the Q1 FY2026 Form 10-Q (footnote (a)); the numeric feed reflects the recast basis while the annual columns here reflect the as-filed FY2025 10-K. See discrepancies.

• Quarterly cash-flow single quarters are derived from printed year-to-date statements and were cross-checked against the quarterly data feed (Q3 FY25 $938M, Q4 FY25 $893M, Q1 FY26 $401M operating cash flow all agree).

• 4 figure(s) differed between the data feed and the filing; the filing value is shown (see the run's metrics/metrics_tab.json for the audit trail).